Michelle Leona Cecil: A Call to Protect Patient Care and The Nation’s Blood Supply for Blood Disorders Community
Michelle Leona Cecil, Community Digital Advocate at MicroHealth, WFH Susan Skinner Memorial Fund Scholarship Advisory and Selection Committee Member, reposted from Hemophilia Federation of America on LinkedIn:
”The potential impact to the Division of Blood Disorders at the Centers for Disease Control and Prevention (CDC) is not just a funding or structural issue… it’s a patient care issue.
For so many in the bleeding disorders community, this division has played a critical role in:
- Supporting data and research that informs care
- Funding programs that help patients access treatment
- Partnering with providers and organizations to improve outcomes
When something like this is at risk, it creates uncertainty, not just for systems, but for people.
People like those of us living with bleeding disorders.
People who rely on consistent, informed, and supported care.
People whose lives quite literally depend on it.
I’ve seen firsthand how important coordinated care, education, and access are.
When those things are threatened, the ripple effects are real, and they are felt quickly.
This is one of those moments where awareness matters.
- Pay attention to what’s happening
- Ask questions
- Reach out to your representatives
- Support organizations doing this work every day
Because decisions made at this level don’t stay at this level, they show up in exam rooms, pharmacies, and everyday life.
If you’re part of this community – patients, caregivers, providers, advocates… your voice matters right now.
Can I count on you to join the Hemophilia Federation of America in taking action?
Can I count on you to share our concerns about the nations blood supply remaining safe?”
Quoting Hemophilia Federation of America‘s post:
”It has been one year since staff from the CDC’s Division of Blood Disorders were placed on administrative leave.
Since April 1, 2025, critical programs serving the bleeding disorders community have lacked the leadership and expertise needed to sustain them.
Join HFA for a national community organizing call to receive updates and hear from partners actively working to reinstate these essential staff and services.
Wednesday, April 8
7:00–8:00 PM EDT
This session will include updates, community perspectives, and opportunities for engagement.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series